357 related articles for article (PubMed ID: 16309754)
1. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
Lee E; Pavy M; Young N; Freeman C; Lobigs M
Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754
[TBL] [Abstract][Full Text] [Related]
2. Unique heparan sulfate from shrimp heads exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus.
Chen J; Yamada S; Hama Y; Shetty AK; Kobayashi T; Oda H; Seiki K; Kim E; Kimura T; Takahashi N; Hidari KI; Suzuki T; Suzuki Y; Sugahara K
Biochem Biophys Res Commun; 2011 Aug; 412(1):136-42. PubMed ID: 21806963
[TBL] [Abstract][Full Text] [Related]
3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71.
Pourianfar HR; Poh CL; Fecondo J; Grollo L
Virus Res; 2012 Oct; 169(1):22-9. PubMed ID: 22771616
[TBL] [Abstract][Full Text] [Related]
5. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus.
Nyberg K; Ekblad M; Bergström T; Freeman C; Parish CR; Ferro V; Trybala E
Antiviral Res; 2004 Jul; 63(1):15-24. PubMed ID: 15196816
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
[TBL] [Abstract][Full Text] [Related]
8. Dengue and other emerging flaviviruses.
Solomon T; Mallewa M
J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
[TBL] [Abstract][Full Text] [Related]
9. Mouse and hamster models for the study of therapy against flavivirus infections.
Charlier N; De Clercq E; Neyts J
Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes.
Hilgard P; Stockert R
Hepatology; 2000 Nov; 32(5):1069-77. PubMed ID: 11050058
[TBL] [Abstract][Full Text] [Related]
11. Rodent models for the study of therapy against flavivirus infections.
Charlier N; Leyssen P; De Clercq E; Neyts J
Antiviral Res; 2004 Aug; 63(2):67-77. PubMed ID: 15321702
[TBL] [Abstract][Full Text] [Related]
12. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
[TBL] [Abstract][Full Text] [Related]
13. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
Talarico LB; Pujol CA; Zibetti RG; Faría PC; Noseda MD; Duarte ME; Damonte EB
Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
[TBL] [Abstract][Full Text] [Related]
15. Strategies for the treatment of dengue virus infections: a narrative account.
De Clercq E
Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus.
Germi R; Crance JM; Garin D; Guimet J; Lortat-Jacob H; Ruigrok RW; Zarski JP; Drouet E
Virology; 2002 Jan; 292(1):162-8. PubMed ID: 11878919
[TBL] [Abstract][Full Text] [Related]
17. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses.
Mackenzie JS; Gubler DJ; Petersen LR
Nat Med; 2004 Dec; 10(12 Suppl):S98-109. PubMed ID: 15577938
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of three alphaherpesviruses (herpes simplex 1 and 2 and pseudorabies virus) by heparin, heparan and other sulfated polyelectrolytes.
Ramos-Kuri M; Barron Romero BL; Aguilar-Setien A
Arch Med Res; 1996; 27(1):43-8. PubMed ID: 8867366
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate.
Waarts BL; Aneke OJ; Smit JM; Kimata K; Bittman R; Meijer DK; Wilschut J
Virology; 2005 Mar; 333(2):284-92. PubMed ID: 15721362
[TBL] [Abstract][Full Text] [Related]
20. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
